Suzhou Historical Cash Flow
| 688137 Stock | 34.70 1.11 3.30% |
Analysis of Suzhou Novoprotein cash flow over time is an excellent tool to project Suzhou Novoprotein future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 36 M or End Period Cash Flow of 1 B as it is a great indicator of Suzhou Novoprotein ability to facilitate future growth, repay debt on time or pay out dividends.
Suzhou |
About Suzhou Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Suzhou balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Suzhou's non-liquid assets can be easily converted into cash.
Suzhou Novoprotein Cash Flow Chart
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Suzhou Novoprotein to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Suzhou Novoprotein operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Suzhou Novoprotein's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Suzhou Novoprotein current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Suzhou Novoprotein's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 1 B, whereas Capital Expenditures is forecasted to decline to about 36 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Other Non Cash Items | 2.8M | 4.6M | 5.3M | 3.9M | Depreciation | 20.5M | 22.5M | 25.9M | 14.8M |
Suzhou Novoprotein cash flow statement Correlations
Click cells to compare fundamentals
Suzhou Novoprotein Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Suzhou Novoprotein cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 11.8M | 70.0M | 36.8M | 44.9M | 51.7M | 36.0M | |
| End Period Cash Flow | 68.6M | 189.4M | 929.3M | 863.7M | 993.2M | 1.0B |
Currently Active Assets on Macroaxis
Other Information on Investing in Suzhou Stock
The Cash Flow Statement is a financial statement that shows how changes in Suzhou balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Suzhou's non-liquid assets can be easily converted into cash.